A citation-based method for searching scientific literature

Lucy S Jun, Rohn L Millican, Eric D Hawkins, Debra L Konkol, Aaron D Showalter, Michael E Christe, M Dodson Michael, Kyle W Sloop. Diabetes 2015
Times Cited: 36







List of co-cited articles
361 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
R W Gelling, X Q Du, D S Dichmann, J Romer, H Huang, L Cui, S Obici, B Tang, J J Holst, C Fledelius,[...]. Proc Natl Acad Sci U S A 2003
375
41

Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.
Young Lee, May-Yun Wang, Xiu Quan Du, Maureen J Charron, Roger H Unger. Diabetes 2011
226
38

Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Bilal A Omar, Birgitte Andersen, Jacob Hald, Kirsten Raun, Erica Nishimura, Bo Ahrén. Diabetes 2014
54
27

Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Christine Longuet, Ana M Robledo, E Danielle Dean, Chunhua Dai, Safina Ali, Ian McGuinness, Vincent de Chavez, Patricia M Vuguin, Maureen J Charron, Alvin C Powers,[...]. Diabetes 2013
114
25

Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway.
May-Yun Wang, Hai Yan, Zhiqing Shi, Matthew R Evans, Xinxin Yu, Young Lee, Shiuhwei Chen, Annie Williams, Jacques Philippe, Michael G Roth,[...]. Proc Natl Acad Sci U S A 2015
63
25

Metabolic manifestations of insulin deficiency do not occur without glucagon action.
Young Lee, Eric D Berglund, May-yun Wang, Xiaorong Fu, Xinxin Yu, Maureen J Charron, Shawn C Burgess, Roger H Unger. Proc Natl Acad Sci U S A 2012
93
25

The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice.
Adam P Chambers, Joyce E Sorrell, April Haller, Karen Roelofs, Chelsea R Hutch, Ki-Suk Kim, Ruth Gutierrez-Aguilar, Bailing Li, Daniel J Drucker, David A D'Alessio,[...]. Cell Metab 2017
115
25


Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
Kyle W Sloop, Julia Xiao-Chun Cao, Angela M Siesky, Hong Yan Zhang, Diane M Bodenmiller, Amy L Cox, Steven J Jacobs, Julie S Moyers, Rebecca A Owens, Aaron D Showalter,[...]. J Clin Invest 2004
155
22

Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes.
Vivi R Steenberg, Signe M Jensen, Jens Pedersen, Andreas N Madsen, Johanne A Windeløv, Birgitte Holst, Bjørn Quistorff, Steen S Poulsen, Jens J Holst. Diabetologia 2016
29
27

Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist.
Nicolas Damond, Fabrizio Thorel, Julie S Moyers, Maureen J Charron, Patricia M Vuguin, Alvin C Powers, Pedro L Herrera. Elife 2016
42
22

Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes.
Johan Farngren, Margaretha Persson, Anja Schweizer, James E Foley, Bo Ahrén. J Clin Endocrinol Metab 2012
63
19

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
19

Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.
Safina Ali, Benjamin J Lamont, Maureen J Charron, Daniel J Drucker. J Clin Invest 2011
79
19

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
S L Conarello, G Jiang, J Mu, Z Li, J Woods, E Zycband, J Ronan, F Liu, R Sinha Roy, L Zhu,[...]. Diabetologia 2007
152
19

Direct effect of GLP-1 infusion on endogenous glucose production in humans.
M Seghieri, E Rebelos, A Gastaldelli, B D Astiarraga, A Casolaro, E Barsotti, A Pocai, M Nauck, E Muscelli, E Ferrannini. Diabetologia 2013
83
16

Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss.
Fabrizio Thorel, Virginie Népote, Isabelle Avril, Kenji Kohno, Renaud Desgraz, Simona Chera, Pedro L Herrera. Nature 2010
750
16

Glucagon antagonism as a potential therapeutic target in type 2 diabetes.
J I Bagger, F K Knop, J J Holst, T Vilsbøll. Diabetes Obes Metab 2011
83
16

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.
Helga Ellingsgaard, Irina Hauselmann, Beat Schuler, Abdella M Habib, Laurie L Baggio, Daniel T Meier, Elisabeth Eppler, Karim Bouzakri, Stephan Wueest, Yannick D Muller,[...]. Nat Med 2011
500
16

Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation.
E Danielle Dean, Mingyu Li, Nripesh Prasad, Scott N Wisniewski, Alison Von Deylen, Jason Spaeth, Lisette Maddison, Anthony Botros, Leslie R Sedgeman, Nadejda Bozadjieva,[...]. Cell Metab 2017
83
16



Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.
P Shah, A Vella, A Basu, R Basu, W F Schwenk, R A Rizza. J Clin Endocrinol Metab 2000
298
13

A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.
P Marchetti, R Lupi, M Bugliani, C L Kirkpatrick, G Sebastiani, F A Grieco, S Del Guerra, V D'Aleo, S Piro, L Marselli,[...]. Diabetologia 2012
160
13

Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake.
Jaimini Cegla, Rachel C Troke, Ben Jones, George Tharakan, Julia Kenkre, Katherine A McCullough, Chung Thong Lim, Nassim Parvizi, Mohamed Hussein, Edward S Chambers,[...]. Diabetes 2014
83
13

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C Broedl, Hans-Juergen Woerle. J Clin Invest 2014
622
13

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?
Nicolai J Wewer Albrechtsen, Bolette Hartmann, Simon Veedfald, Johanne A Windeløv, Astrid Plamboeck, Kirstine N Bojsen-Møller, Thomas Idorn, Bo Feldt-Rasmussen, Filip K Knop, Tina Vilsbøll,[...]. Diabetologia 2014
118
13

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
13

The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty.
Astrid Plamboeck, Simon Veedfald, Carolyn F Deacon, Bolette Hartmann, André Wettergren, Lars B Svendsen, Søren Meisner, Claus Hovendal, Tina Vilsbøll, Filip K Knop,[...]. Am J Physiol Gastrointest Liver Physiol 2013
104
13

Fibroblast growth factor 21 mediates specific glucagon actions.
Kirk M Habegger, Kerstin Stemmer, Christine Cheng, Timo D Müller, Kristy M Heppner, Nickki Ottaway, Jenna Holland, Jazzminn L Hembree, David Smiley, Vasily Gelfanov,[...]. Diabetes 2013
150
13

Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.
Jesper Gromada, Isobel Franklin, Claes B Wollheim. Endocr Rev 2007
398
13

Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats.
Y Nie, M Nakashima, P L Brubaker, Q L Li, R Perfetti, E Jansen, Y Zambre, D Pipeleers, T C Friedman. J Clin Invest 2000
117
13




Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides.
Chika Watanabe, Yusuke Seino, Hiroki Miyahira, Michiyo Yamamoto, Ayako Fukami, Nobuaki Ozaki, Yoshiko Takagishi, Jun Sato, Tsutomu Fukuwatari, Katsumi Shibata,[...]. Diabetes 2012
35
14

Glycemic control in mice with targeted disruption of the glucagon receptor gene.
Janice C Parker, Kim M Andrews, Melanie R Allen, Jeffrey L Stock, John D McNeish. Biochem Biophys Res Commun 2002
105
13

Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells.
Yoshitaka Hayashi, Michiyo Yamamoto, Hiroyuki Mizoguchi, Chika Watanabe, Ryoichi Ito, Shiori Yamamoto, Xiao-yang Sun, Yoshiharu Murata. Mol Endocrinol 2009
71
13

Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.
M Furuta, H Yano, A Zhou, Y Rouillé, J J Holst, R Carroll, M Ravazzola, L Orci, H Furuta, D F Steiner. Proc Natl Acad Sci U S A 1997
327
13

Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys.
Haruka Okamoto, Jinrang Kim, JohnPaul Aglione, Joseph Lee, Katie Cavino, Erqian Na, Ashique Rafique, Jee Hae Kim, Joyce Harp, David M Valenzuela,[...]. Endocrinology 2015
46
13

Glucagon Couples Hepatic Amino Acid Catabolism to mTOR-Dependent Regulation of α-Cell Mass.
Mark J Solloway, Azadeh Madjidi, Chunyan Gu, Jeff Eastham-Anderson, Holly J Clarke, Noelyn Kljavin, Jose Zavala-Solorio, Lance Kates, Brad Friedman, Matt Brauer,[...]. Cell Rep 2015
88
13

Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.
Jinrang Kim, Haruka Okamoto, ZhiJiang Huang, Guillermo Anguiano, Shiuhwei Chen, Qing Liu, Katie Cavino, Yurong Xin, Erqian Na, Rachid Hamid,[...]. Cell Metab 2017
77
13

Insulin Secretion Depends on Intra-islet Glucagon Signaling.
Berit Svendsen, Olav Larsen, Maria Buur Nordskov Gabe, Charlotte Bayer Christiansen, Mette M Rosenkilde, Daniel J Drucker, Jens Juul Holst. Cell Rep 2018
113
13

Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors.
Dominique Dardevet, Mary Courtney Moore, Catherine A DiCostanzo, Ben Farmer, Doss W Neal, Wanda Snead, Margaret Lautz, Alan D Cherrington. Am J Physiol Gastrointest Liver Physiol 2005
40
11


Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.
L Ohlsson, W Alsalim, R D Carr, A Tura, G Pacini, A Mari, B Ahrén. Diabetes Obes Metab 2013
21
19

Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.
Torsten P Vahl, Miyuki Tauchi, Timothy S Durler, Eileen E Elfers, Timothy M Fernandes, Ronald D Bitner, Kay S Ellis, Stephen C Woods, Randy J Seeley, James P Herman,[...]. Endocrinology 2007
235
11

Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia.
Tricia M Tan, Benjamin C T Field, Katherine A McCullough, Rachel C Troke, Edward S Chambers, Victoria Salem, Juan Gonzalez Maffe, Kevin C R Baynes, Akila De Silva, Alexander Viardot,[...]. Diabetes 2013
124
11

Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function.
Heidi Sørensen, Maria Sörhede Winzell, Christian L Brand, Keld Fosgerau, Richard W Gelling, Erica Nishimura, Bo Ahren. Diabetes 2006
84
11

The metabolic actions of glucagon revisited.
Kirk M Habegger, Kristy M Heppner, Nori Geary, Timothy J Bartness, Richard DiMarchi, Matthias H Tschöp. Nat Rev Endocrinol 2010
184
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.